Navigation Sciences is developing the NaviSci™ system, a real-time image-guided technology for minimally invasive thoracoscopic surgery that enables precise margin measurement during cancer resections. This system addresses the challenge of accurately locating and removing lung and soft tissue cancers, thereby reducing recurrence risk and conserving lung function.
Funding
$4.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Accurate margin assessment during minimally invasive lung cancer surgery is challenging, potentially leading to incomplete resections, increased recurrence risk, and unnecessary removal of healthy lung tissue. Current methods lack real-time guidance and precise margin control, hindering optimal surgical outcomes.
Solution
Navigation Sciences is developing the NaviSci™ system, a real-time image-guided technology designed for minimally invasive thoracoscopic surgery. The NaviSci™ system provides surgeons with real-time navigation and precise margin measurement capabilities during lung and soft tissue cancer resections. By enabling accurate tumor localization and margin control, the system aims to reduce recurrence risk, conserve lung function, improve surgical workflow, and potentially shorten hospital stays. The technology has completed a clinical feasibility trial.
Target Audience
The primary target audience includes thoracic surgeons and hospitals specializing in early-stage lung cancer treatment and soft tissue cancer resections.
Features
- Real-time image guidance for precise tumor localization
- Intraoperative margin assessment to ensure complete resection
- Minimally invasive approach to conserve lung function
- Navigation system designed to improve surgical workflow